Therapeutic Areas Regenerative Medicine / Gene Therapy

Regenerative Medicine / Gene Therapy

Regenerative Medicine / Gene Therapy is a unique and growing area of research. CTI is a leader in regenerative medicine drug and device development. We understand the specific challenges these projects present, including regulatory hurdles, complex logistics around biological sample collection, shipment, and implantation, as well as complicated site training requirements based on unique cell and gene technologies. Our experience includes both autologous and allogeneic stem cells as well as other cell/gene interventions. We work with innovators, key opinion leaders, cutting edge biotechnology/pharmaceutical companies, and investigators on our ongoing programs, as well as participate in industry groups such as the Alliance for Regenerative Medicine (ARM). We are committed to the advancement of important, life-changing therapies, and we support innovation by sponsoring and speaking at industry meetings such as Stem Cell on the Mesa, RegenMed Investor Day, and the Advanced Therapies Summit

John Edwards, MD
Medical Director
Dr. Edwards is an expert in the highly specialized area of stem cell biology and hematology. He is board-certified in pediatrics and pediatric hematology/oncology, and has over 20 years of experience in both patient care and industry work.

 

Edwards

Some of our adult and pediatric experience includes:

Specific areas

  • Acute myeloid leukemia
  • Autoimmune diseases
  • Bladder cancer
  • Beta-Thalassemia
  • Bronchopulmonary Dysplasia
  • Bronchiolitis Obliterans Syndrome (BOS)
  • Childhood cerebral adrenoleukodystrophy
  • Choroideremia
  • Chronic kidney disease
  • Critical limb ischemia and ischemic stroke
  • Crohn's disease
  • Diabetes mellitus
  • Graft versus host disease
  • Hematological malignancies
  • Inborn metabolic disorders
  • Ophthalmology
  • Wound healing

Interventions

  • Adipose-derived stem cells
  • Gene therapies
  • Hematopoietic stem cells
    • Bone marrow
    • Peripheral blood stem cells
    • Umbilical cord blood
  • Hepatocytes
  • Islet cells
  • Liver cells
  • Mesenchymal stem cells
  • Neo-organ transplantation

We offer our sponsors:

Request Information

Icon Contact Small Retina

CTI is ready to help with your next drug development project

Contact Us

CTI has Australian Government Gene Therapy Accreditation

Australia Gene Therapy Accreditation

 

CTI is an accredidated organization under the Gene Techonology Act 2000, given by the Office of the Gene Technology Regulator and Australian Governement Department of Health.

 

Learn More

CTI is a proud member of the Alliance for Regenerative Medicine!

ARM

Learn more